Endogenous Antinociceptive Ligands 515 Neugebauer V, Li W, Bird GC, Han JS (2004) The amygdala and persistent pain. Neuroscientist 10:221–234 Nicholson R, Dixon AK, Spanswick D, Lee K (2005) Noradrenergic receptor mRNA expres- sion in adult rat superficial dorsal horn and dorsal root ganglion neurons. Neurosci Lett 380: 316–321 Niederberger E, Schmidtko A, Gao W, Kuhlein H, Ehnert C, Geisslinger G (2007) Impaired acute and inflammatory nociception in mice lacking the p50 subunit of NF-kappaB. Eur J Pharmacol 559:55–60 Nijenhuis WA, Oosterom J, Adan RA (2001) AgRP(83–132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15:164–171 Nijsen M, Ongenae N, Meulemans A, Coulie B (2005) Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain. Neurogastroenterol Motil 17:423–432 Nishimura K, Hazato T (1993) Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. Biochem Biophys Res Commun 194:713–719 Nishimura S, Fukushima O, Ishikura H, Takahashi T, Matsunami M, Tsujiuchi T, Sekiguchi F, Naruse M, Kamanaka Y, Kawabata A (2009) Hydrogen sulfide as a novel mediator for pancreatic pain in rodents. Gut 58(6):762–770; Epub Nyberg F, Sanderson K, Glamsta EL (1997) The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin. Biopolymers 43:147–156 Oatway MA, Chen Y, Weaver LC (2004) The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain 110:259–268 Obara I, Przewlocki R, Przewlocka B (2004) Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats. Neurosci Lett 360:85–89 Obara I, Przewlocki R, Przewlocka B (2005) Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat. Pain 116:17–25 Ochi T, Motoyama Y, Goto T (2000) The spinal antinociceptive effect of FR140423 is mediated through kyotorphin receptors. Life Sci 66:2239–2245 Ochi T, Ohkubo Y, Mutoh S (2002) Blockade of the antinociceptive effect of spinally administered kyotorphin by naltrindole in mice. Neurosci Lett 322:95–98 Oh DY, Yoon JM, Moon MJ, Hwang J-I, Choe H, Lee JY, Kim JI, Kim S, Rhim H, O’Dell DK, Walker JM, Na HS, Lee MG, Kwon HB, Kim K, Seong JY (2008) Indentification of farne- syl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92. J Biol Chem 283:21054–21064 Ohsawa M, Brailoiu GC, Shiraki M, Dun NJ, Paul K, Tseng LF (2002) Modulation of nociceptive transmission by pituitary adenylate cyclase activating polypeptide in the spinal cord of the mouse. Pain 100:27–34 Ohshiro H, Tonai-Kachi H, Ichikawa K (2008) GPR35 is a functional receptor i n rat dorsal root ganglion neurons. Biochem Biophys Res Commun 365:344–348 Oja SS, Saransaari P (2000) Modulation of taurine release by glutamate receptors and nitric oxide. Prog Neurobiol 62:407–425 Okada M, Nakagawa T, Minami M, Satoh M (2002) Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther 303:66–73 Okamoto K, Bereiter DF, Thompson R, Tashiro A, Bereiter DA (2008) Estradiol replacement modifies c-fos expression at the spinomedullary junction evoked by temporomandibular joint stimulation in ovariectomized female rats. Neuroscience 156:729–736 Okamoto Y, Wang J, Morishita J, Ueda N (2007) Biosynthetic pathways of the endocannabinoid anandamide. Chem Biodivers 4:1842–1857 Okuda-Ashitaka E, Ito S (2000) Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor. Peptides 21:1101–1109 Okuda-Ashitaka E, Minami T, Tachibana S, Yoshihara Y, Nishiuchi Y, Kimura T, Ito S (1998) Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature 392:286–289 516 G. Horvath Olgiati VR, Guidobono F, Netti C, Pecile A (1983) Localization of calcitonin binding sites in rat central nervous system: evidence of its neuroactivity. Brain Res 265:209–215 Oliver KR, Keyvan-Fouladi N (2000) Calcitonin gene-related peptide family receptor localization in the rat central nervous system. Eur J Neurosci 12:S472 Oluyomi AO, Hart SL (1991) Involvement of histamine in naloxone-resistant and naloxone- sensitive models of swim stress-induced antinociception in the mouse. Neuropharmacology 30:1021–1027 Omote K, Hazama K, Kawamata T, Kawamata M, Nakayaka Y, Toriyabe M, Namiki A (2001) Peripheral nitric oxide in carrageenan-induced inflammation. Brain Res 912:171–175 Ortiz JP, Close LN, Heinricher MM, Selden NR (2008) Alpha(2)-noradrenergic antagonist admin- istration into the central nucleus of the amygdala blocks stress-induced hypoalgesia in awake behaving rats. Neuroscience 157:223–228 Osbahr AJ, Nemeroff CB, Luttinger D, Mason GA, Prange AJ (1981) Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone. J Pharmacol Exp Ther 217:645–651 Ossipov MH, Gebhart GF (1983) Absence of antinociceptive effect of alpha-2 agonists microin- jected in the periaqueductal gray of the rat. Brain Res 289:349–354 Ossipov MH, Kovelowski CJ, Wheeler-Aceto H, Cowan A, Hunter JC, Lai J, Malan TP, Porreca F (1996) Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. J Pharmacol Exp Ther 277:784–788 Ossipov MH, Zhang ET, Carvajal C, Gardell L, Quirion R, Dumont Y, Lai J, Porreca F (2002) Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. J Neurosci 22:9858–9867 Oz M (2006) Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Pharmacol Ther 111:114–144 Page NM (2004) Hemokinins and endokinins. Cell Mol Life Sci 61:1652–1663 Palazzo E, De Novellis V, Marabese I, Cuomo D, Rossi F, Berrino L, Rossi F, Maione S (2002) Interaction between vanilloid and glutamate receptors in the central modulation of nociception. Eur J Pharmacol 439:69–75 Paldyova E, Bereczki E, Santha M, Wenger T, Borsodi A, Benyhe S (2008) Noladin ether, a puta- tive endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors. Neurochem Int 52:321–328 Palkovits M (1984) Distribution of neuropeptides in the central nervous system: a review of biochemical mapping studies. Prog Neurobiol 23:151–189 Palkovits M (2000) Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons. Eur J Pharmacol 405:161–166 Palkovits M, Mezey E, Eskay RL (1987) Pro-opiomelanocortin-derived peptides (ACTH/beta- endorphin/ alpha-MSH) in brainstem baroreceptor areas of the rat. Brain Res 436: 323–338 Palmer JA, Higuera ES, Chang L, Chaplan SR (2008) Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. Neuroscience 154:1554–1561 Pan HL, Chen SR, Eisenach JC (1998) Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology 89:1518–1523 Pan HL, Wu ZZ, Zhou HY, Chen SR, Zhang HM, Li DP (2008) Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther 117:141–161 Pan YZ, Li DP, Chen SR, Pan HL (2002) Activation of delta-opioid receptors excites spinally projecting locus coeruleus neurons through inhibition of GABAergic Inputs. J Neurophysiol 88:2675–2683 Panocka I, Sadowski B, Marek P (1987) Adrenalectomy and dexamethasone differentially affect postswim antinociception in mice selectively bred for high and low stress-induced analgesia. Physiol Behav 40:597–601 Endogenous Antinociceptive Ligands 517 Panula P, Aarnisalo AA, Wasowicz K (1996) Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 48:461–487 Parolaro D, Patrini G, Massi P, Mainardi P, Giagnoni G, Sala M, Gori E (1989) Histamine as a central modulator of rat intestinal transit. J Pharmacol Exp Ther 249:324–328 Paszcuk AF, Gadotti VM, Tibola D, Quintao NL, Rodrigues AL, Calixto JB, Santos AR (2007) Anti-hypernociceptive properties of agmatine in persistent inflammatory and neuropathic models of pain in mice. Brain Res 1159:124–133 Patacchini R, Santicioli P, Giuliani S, Maggi CA (2004) Hydrogen sulfide (H2S) stimulates capsaicin-sensitive primary afferent neurons in the rat urinary bladder. Br J Pharmacol 142:31–34 Patacchini R, Maggi CA (2001) Peripheral tachykinin receptors as targets for new drugs. Eur J Pharmacol 429:13–21 Patel S, Naeem S, Kesingland A, Froestl W, Capogna M, Urban L, Fox A (2001) The effects of GABAB agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90:217–226 Pawlak D, Takada Y, Urano T, Takada A (2000) Serotonergic and kynurenic pathways in rats exposed to foot shock. Brain Res Bull 52:197–205 Pedersen LH, Scheel-Kruger J, Blackburn-Munro G (2007) Amygdala GABA-A receptor involve- ment in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury. Pain 127:17–26 Pelegrini-da-Silva A, Martins AR, Prado WA (2005) A new role for the renin-angiotensin system in the rat periaqueductal gray matter: angiotensin receptor-mediated modulation of nociception. Neuroscience 132:453–463 Pellicer F, Lopez-Avila A, Coffeen U, Manuel Ortega-Legaspi J, Angel RD (2007) Taurine in the anterior cingulate cortex diminishes neuropathic nociception: a possible interaction with the glycine(A) receptor. Eur J Pain 11:444–451 Pelligrino DA, Laurito CE, VadeBoncouer TR (1996) Nitric oxide synthase inhibition modu- lates the ventilatory depressant and antinociceptive actions of fourth ventricular infusions of morphine in the awake dog. Anesthesiology 85:1367–1377 Peng HY, Chang HM, Chang SY, Tung KC, Lee SD, Chou D, Lai CY, Chiu CH, Chen GD, Lin TB (2008) Orexin-A modulates glutamatergic NMDA-dependent spinal reflex potentiation via inhibition of NR2B subunit. Am J Physiol Endocrinol Metab 295:E117–E129 Perrin MH, Vale WW (1999) Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci 885:312–328 Pert A, Moody TW, Pert CB, Dewald LA, Rivier J (1980) Bombesin: receptor distribution in brain and effects on nociception and locomotor activity. Brain Res 193:209–220 Pertovaara A (2006) Noradrenergic pain modulation. Prog Neurobiol 80:53–83 Pertovaara A, Ostergard M, Anko ML, Lehti-Koivunen S, Brandt A, Hong W, Korpi ER, Panula P (2005) RFamide-related peptides signal through the neuropeptide FF receptor and regulate pain-related responses in the rat. Neuroscience 134:1023–1032 Pertwee RG (2001) Cannabinoid receptors and pain. Prog Neurobiol 63:569–611 Pertwee RG (2007) GPR55: a new member of the cannabinoid receptor clan? Br J Pharmacol 152:984–986 Pettibone DJ, Hess JF, Hey PJ, Jacobson MA, Leviten M, Lis EV, Mallorga PJ, Pascarella DM, Snyder MA, Williams JB, Zeng Z (2002) The effects of deleting the mouse neurotensin recep- tor NTR1 on central and peripheral responses to neurotensin. J Pharmacol Exp Ther 300: 305–313 Pezet S, Malcangio M, McMahon SB (2002) BDNF: a neuromodulator in nociceptive pathways? Brain Res Rev 40:240–249 Pham T, Carrega L, Sauze N, Fund-Saunier O, Devaux C, Peragut JC, Saadjian A, Guieu R (2003) Supraspinal antinociceptive effects of mu and delta agonists involve modulation of adenosine uptake. Anesthesiology 98:459–464 518 G. Horvath Pieretti S, Di Giannuario A, De Felice M, Perretti M, Cirino G (2004) Stimulus-dependent speci- ficity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides. Pain 109:52–63 Pilcher WH, Joseph SA, Mcdonald JV (1988) Immunocytochemical localization of pro- opiomelanocortin neurons in human-brain areas subserving stimulation analgesia. J Neurosurg 68:621–629 Pinter E, Helyes Z, Szolcsanyi J (2006) Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 112:440–456 Pinthong D, Wright IK, Hanmer C, Millns P, Mason R, Kendall DA, Wilson VG (1995) Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 351:10–16 Piovezan AP, D’Orleans-Juste P, Tonussi CR, Rae GA (1997) Endothelins potentiate formalin- induced nociception and paw edema in mice. Can J Physiol Pharmacol 75:596–600 Pitcher MH, Price TJ, Entrena JM, Cervero F (2007) Spinal NKCC1 blockade inhibits TRPV1- dependent allodynia. Mol Pain 3:17 Pittman QJ, Blume HW, Renaud LP (1981) Connections of the hypothalamic paraventricular nucleus with the neurohypophysis, median-eminence, amygdala, lateral septum and midbrain periaqueductal gray - an electro-physiological study in the rat. Brain Res 215:15–28 Pivonello R, Ferone D, Lombardi G, Colao A, Lamberts SW, Hofland LJ (2007) Novel insights in dopamine receptor physiology. Eur J Endocrinol 156:S13–S21 Placzek EA, Okamoto Y, Ueda N, Barker EL (2008) Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. J Neurochem 107:987–1000 Poisbeau P, Patte-Mensah C, Keller AF, Barrot M, Breton JD, Luis-Delgado OE, Freund-Mercier MJ, Mensah-Nyagan AG, Schlichter R (2005) Inflammatory pain upregulates spinal inhibition via endogenous neurosteroid production. J Neurosci 25:11768–11776 Poole S, Cunha FQ, Selkirk S, Lorenzetti BB, Ferreira SH (1995) Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol 115:684–688 Poon A, Sawynok J (1998) Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 74:235–245 Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao JQ, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC (2002) Characterization of a novel endocannabi- noid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301:1020–1024 Portugal-Santana P, Doretto MC, Tatsuo MAKF, Duarte IDG (2004) Involvement of prolactin, vasopressin and opioids in post-ictal antinociception induced by electroshock in rats. Brain Res 1003:1–8 Prado WA, Pelegrini-da-Silva A, Martins AR (2003) Microinjection of renin-angiotensin system peptides in discrete sites within the rat periaqueductal gray matter elicits antinociception. Brain Res 972:207–215 Prell GD, Green JP (1986) Histamine as a neuroregulator. Annu Rev Neurosci 9:209–254 Price J, Mudge AW (1983) A subpopulation of rat dorsal-root ganglion neurons is catecholamin- ergic. Nature 301:241–243 Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM (2004) Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N- arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 141:1118–1130 Proudfit HK (1988) Pharmacologic evidence for the modulation of nociception by noradrenergic neurons. Prog Brain Res 77:357–370 Proudfit HK, Clark FM (1991) The projections of locus coeruleus neurons to the spinal cord. Prog Brain Res 88:123–141 Prusakiewicz JJ, Kingsley PJ, Kozak KR, Marnett LJ (2002) Selective oxygenation of N- arachidonylglycine by cyclooxygenase-2. Biochem Biophys Res Commun 296:612–617 Przewlocka B, Mika J, Labuz D, Toth G, Przewlocki R (1999) Spinal analgesic action of endomor- phins in acute, inflammatory and neuropathic pain in rats. Eur J Pharmacol 367:189–196 Endogenous Antinociceptive Ligands 519 Przewlocki R, Labuz D, Mika J, Przewlocka B, Tomboly C, Toth G (1999) Pain inhibition by endomorphins. Ann N Y Acad Sci 897:154–164 Qu K, Lee SW, Bian JS, Low CM, Wong PTH (2008) Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int 52:155–165 Qu ZX, Isaac L (1993) Dynorphin A (1–13) potentiates dynorphin A (1–17) on loss of the tail flick reflex intrathecal injection in the rat. Brain Res 610:340–343 Quartara L, Maggi CA (1998) The tachykinin NK1 receptor. Part II: distribution and pathophysio- logical roles. Neuropeptides 32:1–49 Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Kakriyannis A, Malan TP Jr (2003) Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 99:955–960 Raasch W, Regunathan S, Li G, Reeis DJ (1995) Agmatine is widely and unequally distributed in rat organs. Ann N Y Acad Sci 763:330–334 Racz I, Bilkei-Gorzo A, Markert A, Stamer F, Gothert M, Zimmer A (2008) Anandamide effects on 5-HT3 receptors in vivo. Eur J Pharmacol 596:98–101 Rady JJ, Fujimoto JM (2002) Nociceptin and dynorphin A(1–17) produce antianalgesia trough independent systems in mice. Life Sci 70:1085–1093 Raffa RB, Schupsky JJ, Lee DKH, Jacoby HI (1996) Characterization of endothelin-induced noci- ception in mice: evidence for a mechanistically distinct analgesic model. J Pharmacol Exp Ther 278:1–7 Raffa RB, Stone DJ, Hipp SJ (1999) Differential cholera-toxin sensitivity of supraspinal antinoci- ception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice. Neurosci Lett 263:29–32 Raghavendra V, Agrewala JN, Kulkarni SK (2000) Melatonin reversal of lipopolysacharides- induced thermal and behavioral hyperalgesia in mice. Eur J Pharmacol 395:15–21 Raghavendra V, Chopra K, Kulkarni SK (1999) Brain renin angiotensin system (RAS) in stress- induced analgesia and impaired retention. Peptides 20:335–342 Raghavendra V, Kulkarni SK (1999) Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors. Brain Res 834:178–181 Raghavendra V, Kulkarni SK (2000) Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. Eur J Pharmacol 409:279–289 Raigorodsky G, Urca G (1990) Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualate modulates the action of N-methyl-D-aspartate. Eur J Pharmacol 182:37–47 Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC (1997) Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 277:968–971 Ramaswamy S, Viswanatham S, Bapna JS (1985) Prolactin analgesia: tolerance and cross- tolerance with morphine. Eur J Pharmacol 112:123–125 Rane K, Sollevi A, Segerdahl M (2000) Intrathecal adenosine administration in abdominal hysterectomy lacks analgesic effect. Acta Anaesthesiol Scand 44:868–872 Rashid MH, Furue H, Yoshimura M, Ueda H (2006) Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain 125:125–135 Rashid MH, Ueda H (2002) Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res 953:53–62 Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92:179–212 Reddy DS, Kulkarni SK (1997) Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice. Eur J Pharmacol 337:19–25 Regaya I, Pham T, Andreotti N, Sauze N, Carrega L, Martin-Eauclaire MF, Jouirou B, Peragut JC, Vacher H, Rochat H, Devaux C, Sabatier JM, Guieu R (2004) Small conductance calcium- activated K+ channels, SkCa, but not voltage-gated K+ (Kv) channels, are implicated in the antinociception induced by CGS21680, a A2A adenosine receptor agonist. Life Sci 76:367–377 520 G. Horvath Reimann W, Schlutz H, Selve N (1999) The antinociceptive effects of morphine, desipramine, and serotonin and their combinations after intrathecal injection in the rat. Anesth Analg 88:141–145 Reinscheid RK, Nothacker H-P, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, Civelli O (1995) Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270:792–794 Reinscheid RK, Nothacker H-P, Civelli O (2000) The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice. Peptides 21:901–906 Reis DJ, Regunathan S (2000) Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 21:187–193 Reis GM, Duarte ID (2007) Involvement of chloride channel coupled GABA(C) receptors in the peripheral antinociceptive effect induced by GABA(C) receptor agonist cis-4-aminocrotonic acid. Life Sci 80:1268–1273 Reiter RJ (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 12:151–180 Ren K, Wei F, Dubner R, Murphy A, Hoffman GE (2000) Progesterone attenuates persistent inflammatory hyperalgesia in female rats: involvement of spinal NMDA receptor mechanisms. Brain Res 865:272–277 Ren X, Noda Y, Mamiya T, Nagai T, Nabeshima T (2004) A neuroactive steroid, dehy- droepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Behav Brain Res 152:243–250 Renganathan M, Cummins TR, Waxman SG (2002) Nitric oxide blocks fast, slow, and persistent Na+ channels in C-type DRG neurons by S-nitrosylation. J Neurophysiol 87:761–775 Reny-Palasse V, Monier C, Rips R (1989) Opioid involvement in TRH-induced antinociception in the rat following intracerebral administration. Pain 38:193–201 Reppert SM, Weaver DR, Godson C (1996) Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci 17:100–102 Riley RC, Trafton JA, Chi SI, Basbaum AI (2001) Presynaptic regulation of spinal cord tachykinin signaling via GABA(B) but not GABA(A) receptor activation. Neuroscience 103:725–737 Rimmerman N, Bradshaw HB, Hughes HV, Chen JS, Hu SS, McHugh D, Vefring E, Jahnsen JA, Thompson EL, Masuda K, Cravatt BF, Burstein S, Vasko MR, Prieto AL, O’Dell DK, Walker JM (2008) N-Palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons. Mol Pharmacol 74:213–224 Rioli V, Gozzo FC, Heimann AS, Linardi A, Krieger JE, Shida CS, Almeida PC, Hyslop S, Eberlin MN, Ferro ES (2003) Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme. J Biol Chem 278:8547–8555 Rittner HL, Brack A, Stein C (2008) Pain and the immune system. Br J Anaesth 101:40–44 Robbins MT, Ness TJ (2008) Footshock-induced urinary bladder hypersensitivity: role of spinal corticotropin-releasing factor receptors. J Pain 9:991–998 Roerig SC (2003) Spinal and supraspinal agmatine activate different receptors to enhance spinal morphine antinociception. Ann N Y Acad Sci 1009:116–126 Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB, Kim KW, Han HJ, Beitz AJ, Na HS, Lee JH (2008) Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechan- ical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain. Anesthesiology 109:879–889 Rokaeus A, Melander T, Hokfelt T, Lundberg JM, Tatemoto K, Carlquist M, Mutt V (1984) A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett 47: 161–166 Romano GJ, Mobbs CV, Howells RD, Pfaff DW (1989) Estrogen regulation of proenkephain gene- expression in the ventromedial hypothalamus of the rat - temporal qualities and synergism with progesterone. Mol Brain Res 5:51–58 Endogenous Antinociceptive Ligands 521 Romero MT, Cooper ML, Komisaruk BR, Bodnar RJ (1988) Gender-specific and gonadectomy- specific effects upon swim analgesia: role of steroid replacement therapy. Physiol Behav 44:257–265 Romero-Sandoval A, Eisenach JC (2007) Clonidine reduces hypersensitivity and alters the bal- ance of pro- and anti-inflammatory leukocytes after local injection at the site of inflammatory neuritis. Brain Behav Immun 21:569–580 Rosa AO, Egea J, Lorrio S, Rojo AI, Cuadrado A, Lopez MG (2008) Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt protoporphyrin has antinociceptive effects against inflammatory pain in the formalin test in mice. Pain 137:332–339 Rosen A, Zhang YX, Lund I, Lundeberg T, Yu LC (2004) Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration. Brain Res 1001:87–94 Rossier J, French ED, R ivier C, Ling N, Guillemin R, Bloom F (1977) Foot-shock induced stress increases beta-endorphin levels in blood but not brain. Nature 270:618–620 Roumy M, Zajac J-M (1998) Neuropeptide FF, pain and analgesia. Eur J Pharmacol 345:1–11 Rousselot P, Papadopoulos G, Merighi A, Poulain DA, Theodosis DT (1990) Oxytocinergic innervation of the rat spinal cord. An electron microscopic study. Brain Res 529: 178–184 Roussy G, Dansereau MA, Dore-Savard L, Belleville K, Beaudet N, Richelson E, Sarret P (2008) Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model. J Neurochem 105:1100–1114 Rubanyi GM, Polokoff MA (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325–394 Ruiz G, Ceballos D, Banos J-E (2004) Behavioral and histological effects of endoneurial administration of nerve growth factor: possible implications in neuropathic pain. Brain Res 1011:1–6 Rupprecht R (2003) Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28:139–168 Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Geasley PJ (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092–1101 Saario SM, Laitinen JT (2007) Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. Basic Clin Pharmacol Toxicol 101:287–293 Sakagawa T, Okuyama S, Kawashima N, Hozumi S, Nakagawasai O, Tadano T, Kisara K, Ichiki T, Inagami T (2000) Pain threshold, learning and formation of brain edema in mice lacking the angiotensin II type 2 receptor. Life Sci 67:2577–2585 Sakai A, Asada M, Seno N, Suzuki H (2008) Involvement of neural cell adhesion molecule signal- ing in glial cell line-derived neurotrophic factor-induced analgesia in a rat model of neuropathic pain. Pain 137:378–388 Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Zadina JE, Kastin AJ, Sakurada T (2000) Differential antagonism of endomorphin-1 and endomorphin-2 spinal nociception by naloxonazine and 3-methoxynaltraxone. Brain Res 881:1–8 Sakurada T, Watanabe C, Okuda K, Sugiyama A, Moriyama T, Sakurada C, Tan-No K, Sakurada S (2002) Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors. Mol Brain Res 98:111–118 Sanchez-Blazquez P, Boronat MA, Olmos G, Garcia-Sevilla JA, Garzon J (2000) Activation of I2-imidazoline receptors channels supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activites at these receptors. Br J Pharmacol 130:146–152 Sanderson K, Nyberg F, Khalil Z (1998) Modulation of peripheral inflammation by locally administered hemorphin-7. Inflamm Res 47:49–55 Sandkuhler J (1996) The organization and function of endogenous antinociceptive system. Prog Neurobiol 50:49–81 522 G. Horvath Sandman CA, Kastin AJ (1981) Intraventricular administration of MSH i nduces hyperalgesia in rats. Peptides 2:231–233 Sandor K, Bolcskei K, McDougall JJ, Schuelert N, Reglodi D, Elekes K, Petho G, Pinter E, Szolcsanyi J, Helyes Z (2009) Divergent peripheral effects of pituitary adenylate cyclase- activating polypeptide-38 on nociception in rats and mice. Pain 141:143–150 Sandor K, Elekes K, Szabo A, Pinter E, Engstrom M, Wurster S, Szolcsanyi J, Helyes Z (2006) Analgesic effects of the somatostatin sst4 receptor selective agonist J-2156 in acute and chronic pain models. Eur J Pharmacol 539:71–75 Sann H, McCarthy PW, Mader M, Schemann M (1995) Choline acetyltransferase-like immunore- activity in small diameter neurones of the rat dorsal root ganglion. Neurosci Lett 198: 17–20 Santicioli P, Del Bianco E, Maggi CA (1993) Adenosine A1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord. Eur J Pharmacol 231:139–142 Sarret P, Esdaile MJ, Perron A, Martinez J, Stroh T, Beaudet A (2005) Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors. J Neurosci 25:8188–8196 Sasamura T, Kuraishi Y (1999) Peripheral and central actions of capsaicin and VR1 receptor. Jpn J Pharmacol 80:275–280 Sawchenko PE, Swanson LW (1982) Immunohistochemical identification of neurons in the par- aventricular nucleus of the hypothalamus that project to the medulla or to the spinal-cord in the rat. J Comp Neurol 205:260–272 Sawynok J (1998) Adenosine receptor activation and nociception. Eur J Pharmacol 347:1–11 Sawynok J, Liu XJ (2003) Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69:313–340 Sawynok J, Sweeney MI, White TD (1989) Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol Sci 10:186–189 Schafer M, Mousa SA, Zhang Q, Carter L, Stein C (1996) Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci U S A 93:6096–6100 Schepers RJ, Mahoney JL, Gehrke BJ, Shippenberg TS (2008) Endogenous kappa-opioid recep- tor systems inhibit hyperalgesia associated with localized peripheral inflammation. Pain 138: 423–439 Schlichter R, Keller AF, De Roo M, Breton LD, Inquimbert P, Poisbeau P (2006) Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways. J Mol Neurosci 28:33–51 Schmidt AP, Bohmer AE, Leke R, Schallenberger C, Antunes C, Pereira MS, Wofchuk ST, Elisabetsky E, Souza DO (2008) Antinociceptive effects of intracerebroventricular adminis- tration of guanine-based purines in mice: evidences for the mechanism of action. Brain Res 1234:50–58 Schmidt C, Peyroux J, Noble F, Fournie-Zaluski M-C, Roques BP (1991) Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests. Eur J Pharmacol 192:253–262 Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361–1368 Schulte G, Robertson B, Fredholm BB, DeLander GE, Shortland P, Molander C (2003) Distribution of antinociceptive adenosine A1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations. Neuroscience 121:907–916 Schwarcz R, Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1–10 Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71:1–51 Scoto GM, Santangelo N, Parenti C (2005) Effect of supraspinal nocistatin on nociceptin/orphanin FQ antagonism of selective opioid analgesia. Neurosci Lett 387:126–129 Endogenous Antinociceptive Ligands 523 Senogles SE (2000) The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine. Mol Pharmacol 58:455–462 Serrano MI, Serrano JS, Fernandez A, Asadi I, Serrano-Martino MC (1998) GABAB receptors and opioid mechanisms involved in homotaurine-induced analgesia. Gen Pharmacol 30:411–415 Sherman SE, Loomis CW (1996) Strychnine-sensitive modulation is selective for non-noxious somatosensory input in the spinal cord of the rat. Pain 66:321–330 Shi TJ, Zhang X, Berge OG, Erickson JC, Palmiter RD, Hokfelt T (1998) Effect of peripheral axotomy on dorsal root ganglion neuron phenotype and autotomy behaviour in neuropeptide Y-deficient mice. Regul Pept 75–76:161–173 Shimada S, Inagaki S, Kubota Y, Kito S, Funaki H, Takagi H (1989) Light and electron- microscopic studies of calcitonin gene-related peptide-like immunoreactive terminals in the central nucleus of the amygdala and the bed nucleus of the stria terminalis of the rat. Exp Brain Res 77:217–220 Shimizu T, Katahira M, Sugawara H, Inoue K, Miyata A (2004) Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord. Regul Pept 123:117–122 Shin MS (2005) Vasoactive intestinal peptide in the amygdala inhibits tail flick reflexes in rats. Brain Res 1040:197–201 Shiomi H, Kuraishi Y, Ueda H, Harada Y, Amano H, Takagi H (1981) Mechanism of kyotorphin- induced release of Met-enkephalin from guinea pig striatum and spinal cord. Brain Res 221:161–169 Shoemaker JL, Joseph BK, Ruckle MB, Mayeux PR, Prather PL (2005) The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. J Pharmacol Exp Ther 314:868–875 Shukla VK, Bansinath M, Dumont M, Lemaire S (1992) Selective involvement of kappa opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1–13)-Tyr- Leu-Phe-Asn-Gly-Pro. Brain Res 591:176–180 Sibilia V, Lattuada N, Rapetti D, Pagani F, Vincenza D, Bulgarelli I, Locatelli V, Guidobono F, Netti C (2006) Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system. Neuropharmacology 51:497–505 Sim LJ, Liu Q, Childers SR, Selley DE (1998) Endomorphin-stimulated [35S]GTPgammaS bind- ing in rat brain: evidence for partial agonist activity at mu-opioid receptors. J Neurochem 70:1567–1576 Simon GS, Dewey WL (1981) Narcotics and diabetes. I. The effects of streptozotocin- induced diabetes on the antinociceptive potency of morphine. J Pharmacol Exp Ther 218: 318–323 Simpson DA, Headley PM, Lumb BM (2008) Selective inhibition from the anterior hypothalamus of C- versus A-fibre mediated spinal nociception. Pain 136:305–312 Singh VP, Jain NK, Kulkarni SK (2001) On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res 915:218–226 Sipe JC, Arbour N, Gerber A, Beutler E (2005) Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol 78:231–238 Skagerberg G, Lindvall O (1985) Organization of diencephalic dopamine neurones projecting to the spinal cord in the rat. Brain Res 342:340–351 Skilling SR, Smullin DH, Larson AA (1990) Differential-effects of C-terminal and N-terminal substance P metabolites on the release of amino-acid neurotransmitters from the spinal cord: potential role in nociception. J Neurosci 10:1309–1318 Skofitsch G, Jacobowitz DM (1985a) Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat. Peptides 6:747–754 Skofitsch G, Jacobowitz DM (1985b) Galanin-like immunoreactivity in capsaicin sensitive sensory neurons and ganglia. Brain Res Bull 15:191–195 Smart D (1999) Orexins: a new family of neuropeptides. Br J Anaesth 83:695–697 524 G. Horvath Smith DJ, Perrotti JM, Crisp T, Cabral MEY, Long JT, Scalzitti JM (1988) The mu opiate receptor is responsible for descending pain inhibition originating in the periaqueductal gray region of the rat brain. Eur J Pharmacol 156:47–54 Smith PA, Moran TD, Abdulla F, Tumber KK, Taylor BK (2007) Spinal mechanisms of NPY analgesia. Peptides 28:464–474 Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR (1994) The pharmaco- logical activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270:219–227 Smullin DH, Skilling SR, Larson AA (1990) Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino-acids in the spinal cord. Pain 42: 93–101 Sofroniew MV, Weindl A, Schrell U, Wetzstein R (1981) Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain. Acta Histochem S24:79–95 Sollevi A, Belfrage M, Lundeberg T, Segerdahl M, Hansson P (1995) Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain. Pain 61:155–158 Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY (2005) Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 54:1402–1407 Song HK, Pan HL, Eisenach JC (1998) Spinal nitric oxide mediates antinociception from intravenous morphine. Anesthesiology 89:215–221 Song P, Zhao Z (2000) Interleukin 2-induced antinociception partially coupled with mu receptor. Cytokine 12:1240–1242 Sorkin LS, Yu AL, Junger H, Doom CM (2002) Antibody directed against GD2 produces mechan- ical allodynia, but not thermal hyperalgesia when administered systemically or intrathecally despite its dependence on capsaicin sensitive afferents. Brain Res 930:67–74 Sorrells SF, Sapolsky RM (2007) An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 21:259–272 Sousa AM, Prado WA (2001) The dual effect of a nitric oxide donor in nociception. Brain R es 897:9–19 Starowicz K, Cristino L, Di Marzo V (2008) TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. Curr Pharm Des 14:42–54 Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, De Novellis V, Di Marzo V (2007) Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J Neurosci 27:13739–13749 Starowicz K, Przewlocki R, Gispen WH, Przewlocka B (2002) Modulation of melanocortin- induced changes in spinal nociception by mu-opioid receptor agonist and antagonist in neuropathic rats. NeuroReport 13:2447–2452 Stein C, Gramsch C, Herz A (1990) Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J Neurosci 10:1292–1298 Steiner AA, Branco LGS, Cunha FQ, Ferreira SH (2001) Role of the haeme oxyge- nase/carbon monoxide pathway in mechanical nociceptor hypersensitivity. Br J Pharmacol 132: 1673–1682 Stone EA, Lin Y, Rosengarten H, Kramer HK, Quartermain D (2003) Emerging evidence for a central epinephrine-innervated alpha 1-adrenergic system that regulates behavioral activation and is impaired in depression. Neuropsychopharmacology 28:1387–1399 Stone TW (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45: 309–379 Stone TW (2000) Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Trends Pharmacol Sci 21:149–154 Suardiaz M, Estivill-Torrus G, Goicoechea C, Bilbao A, Rodriguez de Fonseca F (2007) Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. Pain 133: 99–110 . opioids in post-ictal antinociception induced by electroshock in rats. Brain Res 1003:1–8 Prado WA, Pelegrini-da-Silva A, Martins AR (2003) Microinjection of renin-angiotensin system peptides in discrete. receptor involve- ment in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury. Pain 127:17–26 Pelegrini-da-Silva A, Martins AR,. Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt protoporphyrin has antinociceptive effects against in ammatory pain in the formalin test in mice. Pain 137:332–339 Rosen A, Zhang YX, Lund